CAS: 91-75-8; N-Benzyl-N-((4,5-Dihydro-1H-Imidazol-2-yl)Methyl)Aniline

该化合物是一种化学化合物,被归类为抗脊髓灰质炎,主要用于抗过敏性;它是一非一氮类动物,经常用于眼科治疗,以缓解过敏结膜炎症状;Antazoline功能,阻塞H1肝胺受体,从而减少导致过敏反应的抗苯胺的影响;该化合物通常以白到白晶粉的形式出现,在水和酒精中溶解,适于配制各种药剂;其化学结构包括一个伊米达索尔环,有助于其药理活动;Antazoline还可能表现出一些镇静剂效应,这是第一代抗...

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号36271-19-9 (苄基苯基氨基)乙腈 | CAS号107-15-3 乙二胺 | CAS号13338-49-3 2-氯甲基咪唑啉盐酸盐 | CAS号23582-63-0 Glycine, N-phen... | CAS号409111-05-3 N-benzyl-N-phen... | CAS号501-62-2 非那唑啉 | CAS号100-44-7 氯化苄

合成工艺路线路线简述

  • 36271-19-9 = 91-75-8
    反应条件:1.1 Reagents: Thioacetamide; 3 H,Reflux
    标题:Heterogeneous Cobalt-Catalyzed Degradation Of Azo Compounds Using Alcohols As The Stoichiometric Hydrogen Source
    作者:Panja,Dibyajyoti; Dey,Sadhan; Kundu,Sabuj
    参考文献:Journal Of Environmental Chemical Engineering 日期:2023 卷标:11(2)]

    36271-19-9 = 91-75-8
    反应条件:1.1 Reagents: Thioacetamide Solvents: Ethylenediamine; 3 H,Reflux
    标题:A New And Convenient Synthesis Of Antazoline Derivatives
    作者:Dash,P.; Kudav,D. P.; Parihar,J. A.
    参考文献:Journal Of Heterocyclic Chemistry 日期:2006 卷标:43(2) 页码:401-404]

    = 91-75-8 [标题:Reaction Conditions
    标题:The Influence Of Ph On The Stability Of Antazoline: Kinetic Analysis
    作者:Berzins,Karlis; Grante,Ilze; Nakurte,Ilva; Actins,Andris
    参考文献:Rsc Advances 日期:2015 卷标:5(83) 页码:68179-68186
N-苄基-4,5-二氢-N-苯基-1H-咪唑-2-甲胺磷酸盐置于sodium Hydroxide体系中,用 水 作为反应溶剂,化学反应生成 安他唑啉
参考文献:The Preparation And Characterization Of New Antazoline Salts With Dicarboxylic Acids
标题:The Preparation And Characterization Of New Antazoline Salts With Dicarboxylic Acids
摘要:New Antazoline Salts With Organic Acids (Fumaric Acid,Oxalic Acid,And Maleic Acid) Were Prepared. The Effect Of The Crystallization Solvent And Mechanochemical Treatment On The Crystalline Forms Of These Salts Was Studied. Two Polymorphs Of Antazoline Hydrogen Maleate Were Identified And Their Relative Stability Was Determined. The Molecular Structures Of Antazoline Hydrogen Oxalate And Antazoline Hydrogen Maleate Showed Differences In Antazoline Cation Conformation. In Crystal Structures Of All Salts Both Imidazoline Nitrogens Of Antazoline Cation Are Involved In Hydrogen Bond Formation With Carboxyl Groups Of The Acid.
DOI:10.1080/15421406.2014.905041

海关参考信息

专利信息


专利号:US-11999757-B2
优先权日:2017-11-01
标 题:Synthesis of boronate ester derivatives and uses thereof
发明人:BOYER SERGE HENRI; HECKER SCOTT J; VERZIJL GERARDUS K M; HERMSEN PETRUS J
权利人:MELINTA SUBSIDIARY CORP
摘要:Disclosed herein are methods for the preparation of boronate derivatives in the synthesis of antimicrobial compounds and uses thereof. Disclosed herein includes method of making a compound of Formula (B) by reducing the ketone group of the keto-ester compound of Formula (A), and the reduction can be performed using a Ruthenium based catalyst system or using an alcohol dehydrogenase bioreduction system.

专利号:US-8734846-B2
优先权日:2008-06-16
标 题 :Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles
发明人:ALI MIR M; HRKACH JEFF; ZALE STEPHEN E; ALVAREZ DE CIENFUEGOS LUIS
权利人:BIND BIOSCIENCES INC
摘要:This application provides nanoparticles and methods of making nanoparticles using pre-functionalized poly(ethylene glycol)(also referred to as PEG) as a macroinitiator for the synthesis of diblock copolymers. Ring opening polymerization yields the desired poly(ester)-poly (ethylene glycol)-targeting agent polymer that is used to impart targeting capability to therapeutic nanoparticles. This “polymerization fromâ€? approach typically employs precursors of the targeting agent wherein the reactivity of functional groups of the targeting agent is masked using protecting groups. Also described is a “coupling toâ€? that utilized the poly(ethylene glycol)-targeting agent conjugate where the targeting agent remains in its native un-protected form. This method uses “orthogonalâ€? chemistry that exhibit no cross reactivity towards functional groups typically found within targeting agents of interest.

专利号:US-4310535-A
优先权日:1976-11-30
标题:Combination of drugs and a method for the selective control of the immune reactions evoked in a host by the administration of antigens
发明人:PIERPAOLI WALTER
权利人:PIERPAOLI WALTER
摘要:The invention concerns a new composition or combination of drugs effective to selectively control the immune reactions which are evoked in a host by the administration of antigens. It comprises active components capable of simultaneously blocking the alpha -adrenergic receptors of the cells for catecholamine, blocking the dopaminergic receptors of the cells and increasing the synthesis of serotonin. Preferred drug combinations according to the invention contain in association phentolamine, haloperidol, L-5-hydroxy-tryptophane and possibly dopamine.

专利号:US-9650407-B2
优先权日:2011-11-02
标 题 :Reprogramming of cellular adhesion
发明人:GARTNER ZEV JORDAN; SELDEN NICHOLAS SCOTT; TODHUNTER MICHAEL E; LIANG SAMANTHA ISABEL; WEBER ROBERT JOSEPH; JEE NOEL YOUNGHO; LIU JENNIFER S
权利人:UNIV CALIFORNIA
摘要:Disclosed are membrane-anchored polynucleotides, and compositions comprising the membrane-anchored polynucleotides. Also disclosed are the processes for the synthesis of these compounds, compositions comprising such compounds, and the use of such compounds and compositions in research and therapeutic applications.

专利号:US-5922335-A
优先权日:1995-05-15
标 题:Uses for ascorbyl-phosphoryl-cholesterol in topical compositions
发明人:PTCHELINTSEV DMITRI
权利人:AVON PROD INC
摘要:Novel uses of 3'-(L-ascorbyl-2-o-phosphoryl)-cholesterol, 3'-(L-ascorbyl-3-o-phosphoryl)-cholesterol, structural or functional isomers thereof and salts thereof (referred to collectively as 'APC compounds') are disclosed. Such novel uses include a method of reducing epidermal synthesis of abnormal elastin, especially epidermal synthesis of abnormal elastin that results from exposure to UV radiation. Also disclosed is a novel method of stimulating keratinocyte formation of triglycerides. In addition, a novel method of achieving antioxidant activity, both in the skin and also in topical compositions, is disclosed.

专利号:US-2024279248-A1
优先权日:2017-11-01
标题:Synthesis of boronate ester derivatives and uses thereof
山东玉联药业有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
电话:18560868324👤
⚠️参考联系方式
地址:山东省济南市章丘区刁镇化工工业园区中氟路西500米. 邮编:250204
电话:18560868324
传真:QQ2715295218
邮箱:sales@sjzlpharm.com
联系人:耿经理
手机:18560868324
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

山东省济南市章丘区刁镇化工工业园区中氟路西500米
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
湖北泽泰元化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
电话:027-85588781👤
⚠️参考联系方式
邮件:1197843257@qq.com
销售经理: 何倩经理
联系电话:027-85588781
手机号码: 15871690505
传真号码: 027-85588781
QQ号:1197843257
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

湖北省武汉市新洲镇
⚠️ 未注册 · 未认证企业
注册入口 声明: 数据来源:本内容基于各搜索引擎等公开数据整理,仅作展示用。请自行辨别 📄若企业需抹除相关内容或, 请联系方我们,我们即刻栓除。
武汉鑫灵生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
电话:027-51234320👤
⚠️参考联系方式
邮件:liuxiongbo20001@126.com
销售经理: 刘经理
联系电话:027-51234320
手机号码: 15827170355
传真号码: 027-69811396
QQ号:6901467
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

湖北省武汉市蔡甸区93号
⚠️ 未注册 · 未认证企业
注册入口 声明: 数据来源:本内容基于各搜索引擎等公开数据整理,仅作展示用。请自行辨别 📄若企业需抹除相关内容或, 请联系方我们,我们即刻栓除。
湖北合天化工集团有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
电话:0719-5250325👤
⚠️参考联系方式
邮件:596849714@qq.com
销售经理: 尚小姐经理
联系电话:0719-5250325
手机号码: 15072910073
QQ号:596849714
湖北省丹江口市丹赵路47号
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

湖北省丹江口市丹赵路47号
⚠️ 未注册 · 未认证企业
注册入口 声明: 数据来源:本内容基于各搜索引擎等公开数据整理,仅作展示用。请自行辨别 📄若企业需抹除相关内容或, 请联系方我们,我们即刻栓除。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Balsam P, Koźluk E, Peller M, Piątkowska A, Lodziński P, Kiliszek M, Kołtowski Ł, Grabowski M, Opolski G. Antazoline for termination of atrial fibrillation during the procedure of pulmonary veins isolation. Adv Med Sci. 2015 Sep;60(2):231-5. doi: 10.1016/j.advms.2015.03.002. Epub 2015 Apr 1. doi: 10.5603/CJ.a2013.0121. Epub 2013 Aug 30. doi: 10.1002/bmc.2965. Epub 2013 Jul 12. doi: 10.1016/j.jchromb.2013.04.021. Epub 2013 Apr 20. doi: 10.1186/1745-6215-13-162.
6: Asadpour-Zeynali K, Ghavami R, Esfandiari R, Soheili-Azad P. Simultaneous determination of antazoline and naphazoline by the net analyte signal standard addition method and spectrophotometric technique. J AOAC Int. 2010 Nov-Dec;93(6):1995-2001. doi: 10.1016/j.talanta.2005.07.045. Epub 2005 Aug 24. doi: 10.1016/j.talanta.2003.08.027. PMID: 16316068

合成参考文献


摘要:P. B. Marshall. Brit. J. Pharmacol. 10, 270 (1955).
摘要:Dart, R.C. (ed). Medical Toxicology. Third Edition, Lippincott Williams & Wilkins. Philadelphia, PA. 2004., p. 400
摘要:
摘要:Milhaud D et al; Neuroscience 120 (2): 475-84 (2003)
摘要:Reynolds, J.E.F., Prasad, A.B. (eds.) Martindale-The Extra Pharmacopoeia. 28th ed. London: The Pharmaceutical Press, 1982., p. 1297
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知